Cargando…

Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review

Vaccines developed against SARS-CoV-2 have proven to be highly effective in preventing symptomatic infection. Similarly, prior infection with SARS-CoV-2 has been shown to provide substantial protection against reinfection. However, it has become apparent that the protection provided to an individual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pooley, Nick, Abdool Karim, Salim S., Combadière, Behazine, Ooi, Eng Eong, Harris, Rebecca C., El Guerche Seblain, Clotilde, Kisomi, Masoumeh, Shaikh, Nabila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828372/ https://www.ncbi.nlm.nih.gov/pubmed/36622633 http://dx.doi.org/10.1007/s40121-022-00753-2

Ejemplares similares

Review of the role of big data and digital technologies in controlling COVID-19 in Asia: Public health interest vs. privacy
por: Nageshwaran, Gopinath, et al.
Publicado: (2021)

Risk of long COVID main symptoms after SARS-CoV-2 infection: a systematic review and meta-analysis
por: Marjenberg, Zoe, et al.
Publicado: (2023)

Important changes in the timing of influenza epidemics in the WHO European Region over the past 20 years: virological surveillance 1996 to 2016
por: Caini, Saverio, et al.
Publicado: (2018)

Epidemiology of seasonal influenza in the Middle East and North Africa regions, 2010‐2016: Circulating influenza A and B viruses and spatial timing of epidemics
por: Caini, Saverio, et al.
Publicado: (2018)

Experience from five Asia-Pacific countries during the first wave of the COVID-19 pandemic: Mitigation strategies and epidemiology outcomes
por: El Guerche-Séblain, Clotilde, et al.
Publicado: (2021)

New challenges in modern vaccinology
por: Centlivre, Mireille, et al.
Publicado: (2015)

Epidemiology and timing of seasonal influenza epidemics in the Asia-Pacific region, 2010–2017: implications for influenza vaccination programs
por: El Guerche-Séblain, Clotilde, et al.
Publicado: (2019)

Clinical characteristics and severity of influenza infections by virus type, subtype, and lineage: A systematic literature review
por: Caini, Saverio, et al.
Publicado: (2018)

Authors’ reply: Geographic resolution of surveillance data and influenza prevention in large countries
por: Caini, Saverio, et al.
Publicado: (2017)

The spatiotemporal characteristics of influenza A and B in the WHO European Region: can one define influenza transmission zones in Europe?
por: Caini, Saverio, et al.
Publicado: (2017)

The re-emergence of dengue in China
por: Ooi, Eng Eong
Publicado: (2015)

A tribute to the late Emeritus Professor Chan Soh Ha
por: Ooi, Eng Eong
Publicado: (2021)

Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision‐making and communication
por: Hollingsworth, Rosalind, et al.
Publicado: (2020)

Peptide-Based Vaccination for Antibody Responses Against HIV
por: Combadière, Behazine, et al.
Publicado: (2019)

Strategies for Immunomonitoring after Vaccination and during Infection
por: Adam, Lucille, et al.
Publicado: (2021)

Evolution of Subgenomic RNA Shapes Dengue Virus Adaptation and Epidemiological Fitness
por: Finol, Esteban, et al.
Publicado: (2019)

Minding the “T”s beyond the “B”s: Shaping vaccines for future pandemics
por: Kalimuddin, Shirin, et al.
Publicado: (2023)

Epidemiology and burden of influenza in healthy children aged 6 to 35 months: analysis of data from the placebo arm of a phase III efficacy trial
por: El Guerche-Séblain, Clotilde, et al.
Publicado: (2019)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

Oxygen: viral friend or foe?
por: Gan, Esther Shuyi, et al.
Publicado: (2020)

Changes in Natural Killer Cell Activation and Function during Primary HIV-1 Infection
por: Naranbhai, Vivek, et al.
Publicado: (2013)

Selective Induction of Apoptosis in Mature T Lymphocytes by Variant T Cell Receptor Ligands
por: Combadière, Behazine, et al.
Publicado: (1998)

Original Encounter with Antigen Determines Antigen-Presenting Cell Imprinting of the Quality of the Immune Response in Mice
por: Abadie, Valérie, et al.
Publicado: (2009)

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
por: Karim, Salim S Abdool, et al.
Publicado: (2021)

CD8(+)PD-L1(+)CXCR3(+) polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2–infected patients
por: Adam, Lucille, et al.
Publicado: (2021)

Hospital admissions with influenza and impact of age and comorbidities on severe clinical outcomes in Brazil and Mexico
por: El Guerche-Séblain, Clotilde, et al.
Publicado: (2022)

The impact of the SARS‐CoV‐2 pandemic on global influenza surveillance: Insights from 18 National Influenza Centers based on a survey conducted between November 2021 and March 2022
por: Staadegaard, Lisa, et al.
Publicado: (2023)

Dengue Prevention and 35 Years of Vector Control in Singapore
por: Ooi, Eng-Eong, et al.
Publicado: (2006)

Viral Manipulation of Host Inhibitory Receptor Signaling for Immune Evasion
por: Ong, Eugenia Z., et al.
Publicado: (2016)

A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic
por: Lau, Yuk-Fai, et al.
Publicado: (2009)

Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives
por: Baxter, Cheryl, et al.
Publicado: (2021)

Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules
por: Costa, Vivian Vasconcelos, et al.
Publicado: (2017)

The South African Response to the Pandemic
por: Abdool Karim, Salim S.
Publicado: (2020)

Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection
por: Karim, Salim S Abdool
Publicado: (2021)

Host Transcriptome and Microbiota Signatures Prior to Immunization Profile Vaccine Humoral Responsiveness
por: Gonçalves, Elena, et al.
Publicado: (2021)

Current Status of Dengue Therapeutics Research and Development
por: Low, Jenny G. H., et al.
Publicado: (2017)

Immune Immunomodulation in Coronavirus Disease 2019 (COVID-19): Strategic Considerations for Personalized Therapeutic Intervention
por: Hall, Mark W, et al.
Publicado: (2020)

Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
por: de Alwis, Ruklanthi, et al.
Publicado: (2020)

RNA Viruses, Pandemics and Anticipatory Preparedness
por: Garcia-Blanco, Mariano A., et al.
Publicado: (2022)

Distinct Time Effects of Vaccination on Long-Term Proliferative and IFN-γ–producing T Cell Memory to Smallpox in Humans
por: Combadiere, Behazine, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_1ktvkq2jcsr60v9klk687vbkt2